A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials

Journal of Urology

Volumn 171, Issue 6 I, 2004, Pages 2186-2190

  Sylvester, Richard J ^a   Oosterlinck, Willem ^b   Van Der Meijden, Adrian P M ^b  

^a EORTC DATA CENTER   (Belgium)

^b NONE

Author keywords

Bladder neoplasms; Drug therapy; Meta analysis; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; EPIRUBICIN; MITOMYCIN C; PIRARUBICIN; THIOTEPA;

ARTICLE; BLADDER CANCER; BLADDER PAPILLOMA; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; META ANALYSIS; MULTIPLE CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 2442581163     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000125486.92260.b2     Document Type: Article

References (23)

1. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC Study. MRC Working Party on Urological Cancer. Br J Urol, 57: 680, 1985
2. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer. Br J Urol, 73: 632, 1994
3. Tolley, D. A., Hargreave, T. B., Smith, P. H., Williams, J. L., Grigor, K. M., Parmar, M. K. et al: Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J, 296: 1759, 1988
4. Tolley, D. A., Parmar, M. K. B., Grigor, K. M., Lallemand, G. and the Medical Research Council Superficial Bladder Cancer Working Party: The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of followup. J Urol, 155: 1233, 1996
5. Oosterlinck, W., Kurth, K. H., Schröder, F. H., Bultinck, J., Hammond, B. and Sylvester, R.: A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J Urol, 149: 749, 1993
6. Ali-el-Dein, B., Nabeeh, A., el-Baz, M., Shamaa, S. and Ashamallah, A.: Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study. Br J Urol, 79: 731, 1997
7. Solsona, E., Iborra, I., Ricós, J. V., Monrós, J. L., Casanova, J. and Dumont, R.: Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup. J Urol, 161: 1120, 1999
8. Rajala, P., Liukkonen, T., Raitanen, M., Rintala, E., Kaasinen, E., Helle, M. et al: Transurethral resection with perioperative instillation on interferon-α or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study-FinnBladder III. J Urol, 161: 1133, 1999
9. Rajala, P., Kaasinen, E., Raitanen, M., Liukkonen, T., Rintala, E. and the Finnbladder Group: Perioperative single dose instillation of epirubicin or interferon-α after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study-Finnbladder III long-term results. J Urol, 168: 981, 2002
10. Okamura, K., Ono, Y., Kinukawa, T., Matsuura, O., Yamada, S., Ando, T. et al: Randomized study of single early instillation of (2″R)-4′ -O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma. Cancer, 94: 2363, 2002
11. Abrams, P. H., Choa, R. G., Gaches, C. G., Ashken, M. H. and Green, N. A.: A controlled trial of single dose intravesical adriamycin in superficial bladder tumours. Br J Urol, 53: 585, 1981
12. Burnand, K. G., Boyd, P. J., Mayo, M. E., Shuttleworth, K. E. and Lloyd-Davies, R. W.: Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma. Br J Urol, 48: 55, 1976
13. Kurth, K. H., Maksimovic, P. A., Hop, W. C. J., Schröder, F. H. and Bakker, N. J.: Single-dose intravesical epodyl after TUR of Ta TCC bladder carcinoma. World J Urol, 1: 89, 1983
14. Selvaggi, F. P., De Micheli, P., Pamparana, F. and Sacchetti, G.: Epirubicina endovesicale nella profilassi delle recidive dei tumori superficiali della vesica. Studio multicentrico, randomizzato. Acta Urol Ital, suppl., 1: 331, 1990
15. Zincke, H., Utz, D. C., Taylor, W. F., Myers, R. P. and Leary, F. J.: Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial. J Urol, 129: 505, 1983
16. Oosterlinck, W., Lobel, B., Jakse, G., Malmstrom, P. U., Stockle, M., Sternberg, C. et al: Guidelines on bladder cancer. Eur Urol, 41: 105, 2002
17. Brausi, M., Collette, L., Kurth, K., van der Meijden, A. P., Oosterlinck, W., Witjes, J. A. et al: Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol, 41: 523, 2002
18. Masters, J. R. W., Popert, R. J. M., Thompson, P. M., Gibson, D., Coptcoat, M. J. and Parmar, M. K. B.: Intravesical chemotherapy with epirubicin: a dose response study. J Urol, 161: 1490, 1999
19. Soloway, M. S. and Masters, S.: Urothelial susceptibility to tumor cell implantation: influence of cauterization. Cancer, 46: 1158, 1980
20. Whelan, P., Griffiths, G., Stower, M., Wallace, D., Hetherington, J., Hargreave, T. et al: Preliminary results of a MRC randomised controlled trial of post-operative irrigation of superficial bladder cancer. In: Proceedings of the American Society of Clinical Oncology, vol. 20, abstract 708, 2001
21. Kaasinen, E., Rintala, E., Hellstrom, P., Viitanen, J., Juusela, H., Rajala, P. et al: Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma. Eur Urol, 42: 167, 2002
22. Bouffioux, Ch., Kurth, K. H., Bono, A., Oosterlinck, W., Boeken Kruger, C., de Pauw, M. et al: Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. J Urol, 153: 934, 1995
23. Iborra Juan, I., Ricos Torrent, J. V., Monros Lliso, J. L., Dumont Martinez, R., Casanova Ramon-Borja, J. and Solsona Narbon, E.: Resultados de un estudio de quimioprofilaxis intravesical, prospectivo, doble aleatorio, entre dos drogas: la adriamicina y el mitomycin; y dos modos de iniciar las instilaciones: precoz y tardio. Efecto sobre la recidiva y la progresion. Arch Esp de Urol, 45: 1001, 1992